OXFORD IMMUNOTEC GLOBAL PLC's ticker is OXFD and the CUSIP is G6855A103. A total of 73 filers reported holding OXFORD IMMUNOTEC GLOBAL PLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $6,895,000 | -60.2% | 445,093 | -61.6% | 5.13% | -55.0% |
Q4 2016 | $17,333,000 | -35.9% | 1,159,425 | -46.2% | 11.42% | -31.3% |
Q3 2016 | $27,043,000 | +39.6% | 2,153,092 | 0.0% | 16.62% | -2.0% |
Q2 2016 | $19,378,000 | -9.2% | 2,153,092 | 0.0% | 16.95% | +5.8% |
Q1 2016 | $21,337,000 | -13.8% | 2,153,092 | 0.0% | 16.02% | -7.7% |
Q4 2015 | $24,761,000 | -14.8% | 2,153,092 | 0.0% | 17.35% | +3.8% |
Q3 2015 | $29,067,000 | -3.2% | 2,153,092 | -0.7% | 16.72% | +26.6% |
Q2 2015 | $30,018,000 | -10.1% | 2,167,377 | -8.6% | 13.20% | -4.9% |
Q1 2015 | $33,388,000 | -5.0% | 2,371,328 | -8.1% | 13.88% | +38.4% |
Q4 2014 | $35,127,000 | -10.8% | 2,579,062 | 0.0% | 10.03% | -36.2% |
Q3 2014 | $39,382,000 | -9.3% | 2,579,062 | 0.0% | 15.71% | +2.0% |
Q2 2014 | $43,406,000 | -16.1% | 2,579,062 | 0.0% | 15.41% | +2.9% |
Q1 2014 | $51,762,000 | +3.6% | 2,579,062 | 0.0% | 14.98% | +6.0% |
Q4 2013 | $49,982,000 | – | 2,579,062 | – | 14.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 1,695,888 | $15,704,000 | 7.12% |
First Light Asset Management, LLC | 4,050,040 | $37,503,000 | 6.40% |
Stonepine Capital Management, LLC | 374,431 | $3,467,000 | 3.67% |
Penn Capital Management Company, LLC | 941,579 | $8,724,000 | 1.44% |
Senvest Management, LLC | 1,325,854 | $12,277,000 | 1.44% |
Birchview Capital, LP | 170,303 | $1,577,000 | 1.40% |
Grandeur Peak Global Advisors, LLC | 1,391,318 | $12,884,000 | 1.39% |
HighMark Wealth Management LLC | 114,015 | $1,055,000 | 1.27% |
Consonance Capital Management LP | 1,244,460 | $11,524,000 | 0.86% |
Granahan Investment Management | 814,431 | $7,542,000 | 0.41% |